891 A.2d 416 | Md. Ct. Spec. App. | 2006
In April 2003, appellants, Helen and John Skevofilax, individually and on behalf of their son, Michael Skevofilax, a minor, filed suit in the Circuit Court for Baltimore City against appellees, several defendants involved in the manufacture of pediatric vaccines or ingredients used in those vaccines.
BACKGROUND
Appellants filed suit in the circuit court on April 14, 2003, when Michael was five years old.
On July 11, 2003, appellees had the case removed to the U.S. District Court for the District of Maryland. Two months later, however, on September 5, 2003, the case was returned to the circuit court. The court convened a hearing on November 13, 2003, at which the parties discussed a schedule for discovery and trial. The court then issued a scheduling order that directed, inter alia, the completion of fact discovery by July 30, 2004, identification of appellants’ expert witnesses by
The parties began discovery. According to appellees, they deposed thirteen witnesses and prepared an additional nineteen for deposition by appellants. The parties also exchanged and responded to interrogatories and requests for production of documents. The long list of witnesses and the volume of materials soon led the Skevofilaxes to doubt their ability to meet the fact discovery deadline of July 30, 2004. On June 15, 2004, they requested an extension, which the court granted on July 16, 2004, with the filing of an Amended Scheduling Order. The new scheduling order extended the deadline for fact discovery until December 15, 2004, the deadline for identification of appellants’ expert witnesses by two weeks, to September 15, 2004, and the deadline for identification of appellees’ expert witnesses by one week, to November 8, 2004. The expert discovery deadline remained December 15, 2004. However, the court denied appellants’ request to move the trial date to September 19, 2005, because the presiding judge was scheduled to end his rotation in the civil department on August 31, 2005, and he wanted the trial completed by that time.
On August 2, 2004, the Skevofilaxes requested a modification of the Amended Scheduling Order. They sought and received, in the Second Amended Scheduling Order, three more weeks to identify their expert witnesses, with a new deadline set at October 8, 2004. The expert discovery deadline was extended five days to December 20, 2004.
Discovery continued with appellees retaining expert witnesses and pursuing medical examinations of Michael. Per the Second Amended Scheduling Order, on October 8, 2004, appellants identified eight expert witnesses, four on liability and four on damages. One of the Skevofilaxes’ liability experts was expected to testify on specific causation, that is, to express an opinion on how Michael’s vaccines caused his
Appellants faced another obstacle towards the end of October when they learned that Dr. Bradstreet could not formulate a medical opinion as to the cause of Michael’s autism without the results of certain tests that would aid him in determining Michael’s “genomic susceptibility” to thimerosal. Laboratory clinicians at the University of Arkansas were scheduled to run these tests, but “exigent circumstances” caused them to delay the completion of testing by “at least 30 to 60 days.” Without the test results, Dr. Bradstreet could not formulate an expert opinion, and without Dr. Bradstreet’s expert opinion, appellants could not present him for deposition by appellees. By letter dated October 26, 2004, appellants’ counsel informed appellees that Dr. Bradstreet would not be prepared for his deposition, which, per the Second Amended Scheduling Order, had to be taken no later than November 5, 2004.
On October 29, 2004, appellants requested a continuance of the trial, or, alternatively, dismissal without prejudice. On November 10, 2004, the court convened a hearing, at which it declined to grant a continuance or to dismiss the case without prejudice. Instead, the court directed the parties to collaborate on a new scheduling time line, or, if they could not agree, to submit separate proposals. Based on the parties’ proposals, on November 19, 2004, the court issued a Third Amended Scheduling Order. This order directed that Dr. Bradstreet be deposed no later than December 3, 2004, without questioning about the genetic tests underway in Arkansas, and then again by January 14, 2005, if the results from those tests became available. The expert discovery deadline was extended to January 22, 2005, but the filing date for dispositive motions, February 15, 2005, and the trial date, May 2, 2005, remained the same.
Appellants did not have much time to follow the Third Amended Scheduling Order because shortly after it was entered, appellants’ counsel learned that Dr. Bradstreet was ending his participation in the case. Counsel immediately
On December 1, 2004, appellants renewed their motion of October 29, 2004, to dismiss all claims without prejudice, pursuant to Rule 2-506(b). Attached to the renewed motion was an affidavit of appellants’ counsel stating that Dr. Bradstreet ended his participation “because of professional and personal commitments and time constraints.” Also on December 1, 2004, appellees filed motions for summary judgment on the grounds that without Dr. Bradstreet, appellants had no evidence of specific causation, a required element of their claims.
Appellants appeal the denial of their motion for dismissal without prejudice and the related grant of appellees’ motions for summary judgment. They present the following question for our review:
Did the lower court abuse its discretion when it refused to permit [appellants], including a minor, to dismiss their claims without prejudice when the dismissal request was compelled by the unforeseen withdrawal from the case of an indispensable liability expert?
Because the court denied appellants’ motion to dismiss without prejudice at the same time that it granted appellees’
DISCUSSION
Standard of Review
Maryland Rule 2-506, which governs motions for voluntary dismissal,
(a) By Notice of Dismissal or Stipulation. Except as otherwise provided in these rules or by statute, a plaintiff may dismiss an action without leave of court (1) by filing a notice of dismissal at any time before the adverse party files an answer or a motion for summary judgment or (2) by filing a stipulation of dismissal signed by all parties who have appeared in the action.
(b) By Order of Court. Except as provided in section (a) of this Rule, a plaintiff may dismiss an action only by order of court and upon such terms and conditions as the court deems proper. If a counterclaim has been pleaded prior to the filing of plaintiffs motion for voluntary dismissal, the action shall not be dismissed over the objection of the party who pleaded the counterclaim unless the counterclaim can remain pending for independent adjudication by the court.
Rule 2-506(b) clearly states that, absent a request to dismiss prior to the filing of an answer or a summary judgment motion or a stipulation of the parties, “a plaintiff may dismiss an action only by order of court and upon such terms and conditions as the court deems proper.” Id. (emphasis added). Whether to grant a motion for voluntary dismissal is within the court’s discretion and will not be overturned absent a showing of an abuse of that discretion. Owens-Corning Fiberglas Corp. v. Fibreboard Corp., 95 Md.App. 345, 349-50, 620 A.2d 979 (1993). “A motion for voluntary dismiss
Four Factors Governing Trial Court’s Exercise of Discretion
In Owens-Corning, we advised trial courts to “weight] the equities and giv[e] due regard to all pertinent factors” before ruling on a motion for voluntary dismissal under Rule 2-506(b). Id. Unfortunately, neither this Court nor the Court of Appeals has identified the “pertinent factors” that should be considered by the trial court in deciding a Rule 2-506(b) motion. The parties in the case sub judice urge us to measure this case against four factors that a number of federal courts use to review voluntary dismissal motions under Federal Rule of Civil Procedure 41(a)(2).
Maryland Rule 2-506(b) duplicates Federal Rule 41(a)(2) “in language and purpose.”
The Sixth, Seventh, Eighth, and Tenth Circuits have approved the use of four factors in deciding a voluntary dismissal motion. See County of Santa Fe, N.M. v. Pub. Serv. Co. of N.M., 311 F.3d 1031 (10th Cir.2002); Grover v. Eli Lilly and Co., 33 F.3d 716 (6th Cir.1994); Paulucci v. City of Duluth, 826 F.2d 780 (8th Cir.1987); U.S. v. Outboard Marine Corp., 789 F.2d 497 (7th Cir.1986). The four factors are:
(1) the defendant’s effort and the expense involved in preparing for trial, (2) excessive delay and lack of diligence on the part of the plaintiff in prosecuting the action, (3) insufficient explanation of the need to take a dismissal, and (4) the fact that a motion for summary judgment has been filed by the defendant.
Paulucci, 826 F.2d at 783.
We believe that these four factors further the principle underlying Rule 2-506(b) by providing an analytical framework for the determination of whether there exists plain legal prejudice to the defendant that outweighs the preference for granting the plaintiffs request for a voluntary dismissal. These factors, however, are “by no means exclusive,” and the trial court may consider “any additional factors unique to the context of [the] case.” Ohlander v. Larson, 114 F.3d 1531, 1537 (10th Cir.1997) (holding that “comity, uniform interpretation of the [Hague] Convention and the importance of giving
In applying the above four factors and any other relevant factors, the trial court can weigh one factor more than another, because the particular facts of the case may demand more attention to one factor than to another. See County of Sante Fe, N.M., 311 F.3d at 1049 n. 14 (holding that the “unique” factor in the case outweighed most of the traditional factors that favored granting the motion to dismiss). Moreover, “[e]ach factor need not be resolved in favor of the moving party for dismissal to be appropriate, nor need each factor be resolved in favor of the opposing party for denial of the motion to be proper.” Ohlander, 114 F.3d at 1537. In reaching its conclusion, the trial court “should endeavor to insure substantial justice is accorded to both parties, and therefore the court must consider the equities not only facing the defendant, but also those facing the plaintiff.” Brown v. Baeke, 413 F.3d 1121, 1124 (10th Cir.2005) (quoting County of Sante Fe, N.M., 311 F.3d at 1048); see Owens-Corning, 95 Md.App. at 350, 620 A.2d 979.
In sum, in ruling on a Rule 2-506(b) motion, the task of the trial judge is to determine: (1) the presence, vel non, of each factor, (2) the extent to which the presence or absence of each factor favors one party or the other, and (3) the appropriate weight to be given to each factor, with due regard to the equities of the parties and the principle underlying the rule, to wit, dismissal is preferred unless the defendant will suffer plain legal prejudice.
Application of the Four Factors
1. Effort and Expense
The trial court determined that appellees’ effort and expense in preparing for trial weighed in favor of denying appellants’ motion for voluntary dismissal. In support of this determination, the court found that there was “significant effort and expense on all sides in preparing for trial.” This is undeniably true. By December 1, 2004, the parties already had taken thirty-two depositions, exchanged voluminous documents, and spent considerable time and money developing their respective cases. Nonetheless, appellants point out that most of the witnesses deposed in the instant case are witnesses in other vaccine injury cases around the country. Indeed, nineteen of the depositions that occurred were cross-noticed with other vaccine injury cases, leaving only thirteen depositions that were specific to this case. Regardless of the outcome in the instant case, therefore, the effort expended in preparing and/or deposing the cross-noticed witnesses will not be wasted. See P.R. Mar. Shipping Auth. v. Leith, 668 F.2d 46, 50 (1st Cir.1980) (allowing voluntary dismissal after extensive discovery had been conducted because the discovered information could be used in another pending suit).
2. Diligence
We next consider whether excessive delay or lack of diligence contributed to appellants’ request for dismissal without prejudice. Dismissal with prejudice of a party’s complaint “is warranted when there is a clear record of delay or contumacious conduct by the plaintiff.” Jones v. Smith, 99 F.R.D. 4, 6 (D.Pa.1983); see also Edwards v. Demedis, 118 Md.App. 541, 565, 703 A.2d 240 (1997) (affirming dismissal of claim with prejudice because claim had been pending for more than a year-and-a-half, and, without legitimate reason, plaintiffs requested dismissal one month before trial). Dismissal with prejudice is a harsh sanction that must be proportionate to the transgression of the party whose action is dismissed. See Doe v. Cassel, 403 F.3d 986, 990 (8th Cir.2005). To warrant dismissal with prejudice, therefore, plaintiff must have acted “intentionally as opposed to accidentally or involuntarily.” Id.
The trial court specifically found that there was no lack of diligence on the part of appellants. The court stated: “I will say, as all counsel have stated here, there has been no lack of diligence whatsoever on behalf of [appellants’ counsel] in the
It was not until the unforeseen events of the delay in the test results from the University of Arkansas in October 2004, and the withdrawal of Dr. Bradstreet in November 2004, that appellants’ efforts to comply with their discovery obligations were ultimately frustrated. Even then, appellants promptly notified the court and opposing counsel. All of the aforementioned circumstances, therefore, demonstrated appellants’ diligence in prosecuting their claims in this case.
3. Explanation for the Dismissal
The third factor for our consideration is the sufficiency of appellants’ explanation for their request to have the case dismissed without prejudice. Appellants informed the court that Dr. Bradstreet withdrew from the case for personal reasons. The defendants implied that this reason was pretextual, because Dr. Bradstreet was unwilling or unable to render an expert opinion favorable to appellants’ claims. The trial court stated:
The third [factor], insufficient explanation of a need for a dismissal. There has been the explanation for the dismissal. Whether or not it’s sufficient or not, really is dependent on the facts of this case. And, the facts of this case demonstrate that the plaintiffs have conceded that Dr. Bradstreet*18 is, indeed, the sole expert on specific causation. And, without that opinion, they are unable to prosecute their claims.
We can infer from the above statements that the trial court found appellants’ reasons for Dr. Bradstreet’s withdrawal to be legitimate, but without Dr. Bradstreet’s expert opinion on specific causation, appellants could not prove a prima facie case against appellees. If the trial court had accepted appel-lees’ argument that the reasons for Dr. Bradstreet’s withdrawal were pretextual, it certainly would have said so.
Appellees continue to argue on appeal that Dr. Bradstreet pulled out of the case, not because of personal reasons, but because he received the genetic test results for Michael and they did not support appellants’ claims for damages.
On December 11, 2004, about two-and-a-half weeks after Dr. Bradstreet pulled out of the instant case, he was deposed by appellees in another vaccine injury case. Appellees’ attorney questioned Dr. Bradstreet about his decision to withdraw from the instant case, and Dr. Bradstreet explained that the withdrawal was “[mjostly [his] wife’s decision,” and that “she felt [he] needed to spend more time with the family.” This deposition testimony confirmed the reason that appellants gave for their dismissal request on December 1, 2004. Therefore, we conclude that the trial court properly found that appellants’ reasons for requesting a dismissal without prejudice were sufficient, because their sole expert on specific causation unexpectedly withdrew from participation in this case for reasons unrelated to the viability of appellants’ claims.
4. Pending Summary Judgment Motion
The fourth factor asks whether a motion for summary judgment prompted the motion for dismissal without prejudice. See Pace v. So. Express Co., 409 F.2d 331, 334 (7th Cir.1969) (denying plaintiffs request for voluntary dismissal because, among other things, the defendant had filed and briefed the court on a motion for summary judgment). Courts are hesitant to grant motions for dismissal that are merely attempts to avoid an undesirable consequence of litigation. See Owens-Corning, 95 Md.App. at 350, 620 A.2d 979 (discussing the historical purpose of Rule 2-506 to prevent plaintiffs from dismissing actions for purely tactical reasons); see also Greguski v. Long Island R.R. Co., 163 F.R.D. 221, 224 (S.D.N.Y.1995) (denying plaintiffs request for withdrawal without prejudice because it was a mere substitute for adjournment of trial, which the court previously disallowed); Millsap v. Jane Lamb Mem’l Hosp., 111 F.R.D. 481, 484
In this case, appellees filed motions for summary judgment at the same time that appellants filed their motion to dismiss without prejudice. Appellees filed their motions because appellants’ counsel advised them on November 23, 2004, that Dr. Bradstreet had declined to participate further in the case. Appellants’ motion, therefore, was not filed in response to appellees’ motions in order to avoid an inevitable end to the litigation. When appellees filed their motions for summary judgment, discovery was not complete and the trial date was five months away. Indeed, under the court’s Third Amended Scheduling Order, dispositive motions were not even due until February 15, 2005, more than two months after the filing of appellants’ and appellees’ motions. Although the trial court did not make any determination as to whether this factor favored appellants or appellees, the only conclusion supported by the record in this case is that this factor favors the granting of appellants’ motion to dismiss without prejudice.
Michael’s Status as a Minor
The particular circumstances of the case sub judice present an additional factor that the trial court must consider in deciding a motion to dismiss without prejudice under Maryland Rule 2-506(b) — Michael’s status as a minor. Traditionally, Maryland courts have been sensitive to the legal rights of minors and have had occasion to protect those rights against legislative infringement and prejudice by the minor’s “next friend.” In Piselli v. 75th Street Medical, 371 Md. 188, 808 A.2d 508 (2002), the Court of Appeals held unconstitutional the statute of limitations governing claims by minors against health care providers, because the statute provided that limitations would begin to run prior to a minor attaining the age of majority. See id. at 215-16, 808 A.2d 508.
In Fulton v. K & M Associates, 331 Md. 712, 629 A.2d 716 (1993), the minor plaintiff alleged in his complaint that he suffered lead poisoning while living in certain apartment build
In reversing, the Court of Appeals reasoned that “[h]ad the trial judge not been considering the claim of an infant, the record would support a holding that the trial court did not abuse its discretion in denying the motion for voluntary dismissal without prejudice.” Id. at 717, 629 A.2d 716. Because the plaintiff was a minor, however, the trial court owed him a duty “to insure that the next friend d[id] not prejudice the rights and interests of the minor through conflict of interest, fraud, or neglect.” Id.; see also Berrain v. Katzen, 331 Md. 693, 711, 629 A.2d 707 (1993).
If the circumstances of Fulton did not justify the denial of a motion to dismiss without prejudice under Rule 2-506(b), the facts of this case provide even less justification for denying such motion. In Fulton, there was dilatory and neglectful conduct on the part of the “next friend,” whereas here, the “next friends,” Michael’s parents, prosecuted Michael’s claims with diligence, but were prevented from proceeding with the litigation because of the unexpected withdrawal of a critical expert witness.
Analysis
It is clear from the transcript of the December 21, 2004 hearing that the circuit court carefully considered each of the factors discussed above. We respect its consideration and are cognizant of our deferential standard of review. See Owens-Corning, 95 Md.App. at 349-50, 620 A.2d 979. Nonetheless, we conclude that the trial court abused its discretion under Rule 2-506(b) when it denied appellants’ motion. The court made the first factor, appellees’ effort and expense, determinative of its decision when that factor (a) is not compelling under the facts of the instant case, and (b) was the only one that the court found weighed in appellees’ favor. After considering all of the factors and concluding that to grant appellants’ motion would be “inappropriate,” the court stated:
Critical to the court is the extensive discovery that has been undertaken. The thirteen depositions. The corporate des-ignees that have been noted. The time, effort and expense in briefing the preliminary motions, and gathering discovery, and presenting dispositive motions to the Court, that are relevant to the Court’s consideration.
As previously discussed, a majority of the depositions taken in this case were cross-noticed, and consequently, can be used by appellees in other vaccine injury cases. The remaining “case specific” depositions may not have to be redone or may need only to be updated. Moreover, several expert depositions had not been taken as of the date that the court denied appellants’ motion. Although appellees certainly expended
In addition, all of the other factors in the four factor test weigh in favor of granting appellants’ motion. Appellants diligently prosecuted their claims. They presented to the court a valid reason for their motion for voluntary dismissal— the unexpected withdrawal of their expert witness for personal reasons. Finally, appellants did not file their motion in response to appellees’ motions for summary judgment in order to avoid an inevitable end to the litigation. Therefore, because the record does not support the significance attributed to the first factor by the court, the record clearly cannot justify the determinative weight assigned to that factor by the court over all of the other three factors.
The trial court also failed to give any consideration to the additional factor “unique to the context of [the] case,” Ohlander, 114 F.3d at 1537, — the status of Michael as a minor in prosecuting his claims against appellees. The court expressly analyzed appellants’ motion under Rule 2-506(b) no differently than any other voluntary dismissal motion. In so doing, the trial court failed to discharge its “special duty” to protect the rights and interests of a minor plaintiff. See Fulton, 331 Md. at 717, 629 A.2d 716; Berrain, 331 Md. at 711, 629 A.2d 707. “[E]ven with respect to a discretionary matter, a trial court must exercise its discretion in accordance with correct legal standards.” Alston v. Alston, 331 Md. 496, 504, 629 A.2d 70 (1993); see also Ohlander, 114 F.3d at 1537 (“A clear example of an abuse of discretion exists where the trial court fails to consider the applicable legal standard or the facts upon which the exercise of its discretionary judgment is based.”).
JUDGMENT OF THE CIRCUIT COURT FOR BALTIMORE CITY REVERSED; CASE REMANDED WITH INSTRUCTIONS TO THE TRIAL COURT TO DISMISS ALL CLAIMS OF APPELLANTS AGAINST APPELLEES WITHOUT PREJUDICE; APPELLEES TO PAY COSTS.
. The defendants were Aventis Pasteur, Inc., Wyeth, and Merck & Company, Inc., all of whom manufactured pediatric vaccines distributed in Maryland ("the vaccine manufacturer defendants”), and Eli Lilly and Company, which previously had manufactured thimerosal, a preservative containing mercury used in the aforesaid pediatric vaccines. Appellants also sued Baltimore Gas & Electric Company, alleging that Michael’s injuries were exacerbated by toxic emissions from cool-burning power plants. However, all claims against this defendant were dismissed by the court, and no appeal was noted by appellants. Glax-oSmithKline Biologicals, S.A. and GlaxoSmithKline were added as additional vaccine manufacturer defendants by the second amended complaint, filed on May 24, 2004.
. Prior to filing suit, the Skevofilaxes filed a petition in the U.S. Court of Federal Claims, pursuant to the National Childhood Vaccine Injury Act of 1986. See 42 U.S.C. § 300aa-1, et seq. They withdrew this petition to pursue a civil action in state court.
. All of the negligence claims against appellee Eli Lilly and Company were dismissed by the court by order filed February 19, 2004, and appellants’ motion for reconsideration of such dismissal was denied in June 2004. Thus only the fraud claims remained against Lilly.
. Actually, appellee Eli Lilly and Company filed a motion for summary judgment in May 2004 on the fraud claims against it. The circuit court denied this motion in June 2004 in order for further discovery to take place. Following Dr. Bradstreet's withdrawal from the case, Lilly renewed its motion for summary judgment on December 3, 2004, with the previous arguments about appellants' fraud claims, as well as the effect of Dr. Bradstreet's withdrawal.
. When the court granted appellees' motions for summary judgment on December 21, 2004, it appears to have done so solely on the basis of Dr. Bradstreet’s withdrawal.
. For stylistic purposes, we will use “motion for voluntary dismissal" interchangeably with "motion to dismiss without prejudice" in this opinion.
. Federal Rule of Civil Procedure 41(a)(2) states in part:
(2) By Order of Court. Except as provided in paragraph (1) of this subdivision of this rule, an action shall not be dismissed at the plaintiff’s instance save upon order of the court and upon such terms and conditions as the court deems proper....
. Some federal courts compress these four factors into three factors: (1) "whether the party has presented a proper explanation for its desire to dismiss;’’ (2) "whether a dismissal would result in a waste of judicial time and effort;” and (3) "whether a dismissal will prejudice the defendants.” See Hamm v. Rhone-Poulenc Rorer Pharm., Inc., 187 F.3d 941, 950 (8th Cir. 1999). Other courts discuss similar considerations with the following five factors: "the plaintiff’s diligence in bringing the motion; any ‘undue vexatiousness’ on plaintiff's part; the extent to which the suit has progressed, including the defendant’s efforts and expense in preparation for trial; the duplicative expense of relitigation; and the adequacy of plaintiff’s explanation for the need to dismiss.” See Zagano v. Fordham Univ., 900 F.2d 12, 14 (2d Cir. 1990) (citations omitted).
. Although not raised by the parties or considered by the court in the case sub judice, Rule 2-506(b) expressly authorizes the trial court to grant a motion to dismiss without prejudice "upon such terms and conditions as the court deems proper." The rule "allows the court to prevent prejudice to the defendant in such cases by attaching conditions to the dismissal.” Pontenberg v. Boston Scientific Corp., 252 F.3d 1253,
. Appellees also contend that the Skevofilaxes cannot prove specific causation in Michael's case, because currently the scientific community does not recognize a link between thimerosal and autism. They argue, therefore, that summary judgment was appropriate because causation is a required element of the causes of action pursued by appellants. Appellees rely on Blackmon v. American Home Products Corp., 2005 WL 1503547 (S.D.Tex.2005), in which a U.S. District Court in Texas denied plaintiffs' request for dismissal without prejudice and granted summary judgment to the defendants in a vaccine injury case. As in this case, plaintiffs in Blackmon did not have an expert witness who would testify on specific causation. The Texas court would not allow plaintiffs "to pursue this litigation again later when they may have evidence of causation" because they relied only "on their own conjectures about the facts or on hopes of what future discovery or scientific research might add to their case." Id. Blackmon is readily distinguishable from the case sub judice. Here, the trial court did not rule that no evidence existed in the relevant scientific community to support appellants’ claims. More importantly, Blackmon did not involve the unforeseen withdrawal of a critical expert witness for reasons unrelated to the merits of the case.
. In Berrain, which was decided the same day as Fulton, the Court of Appeals reversed the dismissal of an infant's lead paint claim as a sanction for the "next friend's” failure to cooperate with discovery. The Court stated: "[TJhe trial court has a special duty to protect the rights and interests of the minor plaintiff who is represented by next friend to insure that the next friend does not prejudice those rights and interests through conflict of interest, fraud, or, in this case, neglect.” Berrain, 331 Md. at 711, 629 A.2d 707.
